NANOBIOTIX S.A. SP.ADR (5NRA) — Financial Flexibility Index
NANOBIOTIX S.A. SP.ADR (5NRA) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of €-32.88 Million (operating CF €-33.42 Million minus capex €546.00K) represents 0% of total liabilities (€152.24 Million). Check how tangible is NANOBIOTIX S.A. SP.ADR's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NANOBIOTIX S.A. SP.ADR Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for NANOBIOTIX S.A. SP.ADR across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NANOBIOTIX S.A. SP.ADR.
Annual Financial Flexibility Index for NANOBIOTIX S.A. SP.ADR (2021–2025)
Year-by-year free cash flow to debt coverage for NANOBIOTIX S.A. SP.ADR. Explore 5NRA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | €-32.88 Million | €-33.42 Million | €152.24 Million | ▼ -53.7% |
| 2024 | -0.14x | €-18.70 Million | €-19.55 Million | €133.12 Million | ▼ -10.8% |
| 2023 | -0.13x | €-12.14 Million | €-12.48 Million | €95.74 Million | ▲ +70.3% |
| 2022 | -0.43x | €-37.01 Million | €-37.10 Million | €86.81 Million | ▼ -7.8% |
| 2021 | -0.40x | €-29.64 Million | €-29.87 Million | €74.98 Million | — |